Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cybin Inc. (HELP.NE)

Cybin Inc. (HELP.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 436,657
  • Shares Outstanding, K 49,894
  • Annual Sales, $ 0 K
  • Annual Income, $ -79,055 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -1.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.32
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -3.77
  • Most Recent Earnings $-1.39 on 11/13/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.9000 +11.77%
on 02/09/26
11.4400 -22.81%
on 01/15/26
-1.6200 (-15.50%)
since 01/09/26

Most Recent Stories

More News
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market

EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END

HELP : 6.49 (+1.25%)
AZN : 204.76 (+5.87%)
JNJ : 240.86 (+1.05%)
HELP.NE : 8.8300 (+0.91%)
ABBV : 220.89 (-0.70%)
TAK : 18.28 (+0.99%)

Business Summary

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression,...

See More

Key Turning Points

3rd Resistance Point 9.6117
2nd Resistance Point 9.2433
1st Resistance Point 9.0367
Last Price 8.8300
1st Support Level 8.4617
2nd Support Level 8.0933
3rd Support Level 7.8867

See More

52-Week High 12.1200
Fibonacci 61.8% 10.5080
Fibonacci 50% 10.0100
Fibonacci 38.2% 9.5120
Last Price 8.8300
52-Week Low 7.9000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar